Hirntumoren des Kindes- und Jugendalters

Das histologische Spektrum der ZNS-Tumoren bei Kindern und Jugendlichen unterscheidet sich stark von dem Erwachsener. Über 90 % aller in Deutschland diagnostizierten ZNS-Tumoren werden in Studien oder Registern des Behandlungsnetzwerks HIT eingeschlossen. Ziel sind die Durchführung multimodaler Therapieoptimierungsstudien und die Sicherung qualitätskontrollierter, interdisziplinärer Standards für Diagnostik, Operation, Bestrahlung und Chemotherapie.

• Literatur

• 1 Kaatsch P, Grabow D, Spix C. German Childhood Cancer Registry – Annual Report 2017 (1980–2016). Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI) at the University Medical Center of the Johannes-Gutenberg-University Mainz, 2018
• 2 Wilne S, Collier J, Kennedy C. et al. Presentation of childhood CNS tumours. A systematic review and meta-analysis. Lancet Oncol 2017; 8: 685-695
• 3 Louis DN, Perry A, Reifenberger G. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 2016; 131: 803-820
• 4 Gajjar A, Bowers DC, Karajannis MA. et al. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape. J Clin Oncol 2015; 33: 2986-2998
• 5 Gnekow AK, Walker DA, Kandels D. et al. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤ 16 years) low grade glioma – A final report. Eur J Cancer 2017; 81: 206-225
• 6 Janssens GO, Gandola L, Bolle S. et al. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group. Eur J Cancer 2017; 73: 38-47
• 7 Lannering B, Rutkowski S, Doz F. et al. Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol 2012; 30: 3187-3193
• 8 Sturm D, Orr BA, Toprak UH. et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell 2016; 164: 1060-1072
• 9 Pajtler KW, Witt H, Sill M. et al. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. Cancer Cell 2015; 27: 728-743
• 10 Tallen G, Resch A, Calaminus G. et al. Strategies to improve the quality of survival for childhood brain tumour survivors. Eur J Paediatr Neurol 2015; 19: 619-639